Affordable Access

deepdyve-link
Publisher Website

Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer

Authors
  • Beyer, Susanne1
  • Chen, Fangfang1
  • Meister, Sarah1
  • Czogalla, Bastian1
  • Kolben, Theresa M.1
  • Hester, Anna1
  • Burges, Alexander1
  • Trillsch, Fabian1
  • Schmöckel, Elisa1
  • Mayr, Doris1
  • Mayerhofer, Artur1
  • Mahner, Sven1
  • Jeschke, Udo1
  • Kolben, Thomas1
  • 1 LMU Munich,
Type
Published Article
Journal
Histochemistry and Cell Biology
Publisher
Springer Berlin Heidelberg
Publication Date
May 09, 2020
Volume
154
Issue
2
Pages
189–195
Identifiers
DOI: 10.1007/s00418-020-01873-x
PMID: 32388637
PMCID: PMC7429549
Source
PubMed Central
Keywords
License
Unknown

Abstract

Several risk factors like obesity and hyperlipidemia were described for endometrial cancer. Here, the nuclear NAD-dependent histone-deacetylase Sirtuin1 (SIRT1) seems to be important. SIRT1 is also involved in cell regulatory mechanisms and can serve as tumor promotor or suppressor. Its role in tumor biology is not clear yet. In this study, we evaluated and correlated the SIRT1 expression with patients’ tumor characteristics in endometrioid and clear-cell cancer of the uterus. 65 paraffin-embedded samples of patients with endometrial and clear-cell cancer of the uterus were immunohistochemically stained and SIRT1 expression was evaluated by immunoreactive score. The results were correlated to clinical and pathological tumor characteristics as well as to the expression of ARID1A and β-Catenin. The staining was significantly more intensive in uterine endometrioid carcinoma compared to uterine clear-cell carcinoma ( p = 0.007). The expression of SIRT1 correlated significantly with the membranous expression of β-Catenin ( p = 0.028) and ARID1A ( p = 0.021). Patients with positive Sirtuin1 expression had a significantly better progression-free survival ( p = 0.042), the overall survival showed a trend towards a better prognosis ( p = 0.070). SIRT1 expression seems to be associated with improved progression-free survival in uterine cancer (endometrioid and clear-cell) and is correlated to the tumor suppressors β-Catenin and ARID1A. Further studies are necessary to elucidate the role of SIRT1 in uterine and ovarian cancer and its potential as a therapeutic target.

Report this publication

Statistics

Seen <100 times